Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) via Aptima Combo 2 TMA Assay

 

Click on the below image to view the collection technique

ThinPrep
ThinPrep
Unisex Swab
Aptima Unisex
Aptima Multitest
Aptima Urine

Store specimens at room temperature (15 to 30°C) until transported. DO NOT freeze.

CDC Treatment resources:

NAAT tests are recommended by the CDC for detection.  
 
Chlamydia: Repeat infection with chlamydia is common. Women whose sex partners have not been appropriately treated are at high risk for re-infection. Having multiple chlamydial infections increases a woman’s risk of serious reproductive health complications, including pelvic inflammatory disease and ectopic pregnancy. Women and men with chlamydia should be retested about three months after treatment of an initial infection, regardless of whether they believe that their sex partners were successfully treated.
For Chlamydia, the CDC recommends that the woman and partner be treated with azithromycin, or doxycycline (97% and 98% cure rate respectively).  
Gonorrhea: Only one regimen, dual treatment with ceftriaxone and azithromycin, is recommended for treatment of gonorrhea in the United States.  This treats resistant strains as well.  "Following the spread of gonococcal fluoroquinolone resistance, the cephalosporin antibiotics have been the foundation of recommended treatment for gonorrhea." -CDC
 
CDC (https://www.cdc.gov/std/gisp) and state health departments can provide the most current information on gonococcal susceptibility.
Speciation of strains is not recommended  and is not necessarily an accurate representation of resistance.
If the patient is negative for Chlamydia and Gonorrhea, but still presents with similar symptoms, especially urethritis,  the patient could instead be infected with mycoplasma genitalium.  1-g single dose of azithromycin is the recommended treatment, but more information can be found on DC website. CDC: https://www.cdc.gov/std/tg2015/emerging.htm

Product Insert (click here)